Home » FDA OK’s Mobile App for Assisting Opioid Use Disorder Treatments
FDA OK’s Mobile App for Assisting Opioid Use Disorder Treatments
The FDA granted 510(k) clearance for Pear Therapeutics’ reSET-O, an app designed to help patients with opioid use disorder stick with their recovery programs.
The app is meant to be used with buprenorphine and contingency management, a behavior modification therapy.
After receiving a doctor’s prescription for the app, it can be downloaded onto a mobile device for use with active participation in an opioid use disorder treatment program. It serves as a training, monitoring and reminder tool for patients and healthcare providers.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May